Home › Funds › GENERAL AMERICAN INVESTORS CO INC › SOLV

GENERAL AMERICAN INVESTORS CO INC position in SOLV

SOLVENTUM CORP · Health Care

GENERAL AMERICAN INVESTORS CO INC reported holding 198,709 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$17.5M, representing 1.11% of its reported portfolio and ranking #32 among its reported holdings. GENERAL AMERICAN INVESTORS CO INC has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)198.71K sh
Reported value held$17.52M
Portfolio Weight1.11%
First reportedQ3 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GENERAL AMERICAN INVESTORS CO INC's SOLV position evolved

GENERAL AMERICAN INVESTORS CO INC first disclosed a stake in SOLV in Q3 2024 at 207,350 shares (US$14.5M). The position peaked in Q2 2026 at 377,350 shares, worth US$29.1M. Across 9 filings, GENERAL AMERICAN INVESTORS CO INC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 198,709 shares valued at US$17.5M — a reduction of -178,641 shares quarter over quarter.. Notable position changes include a 78% increase in Q2 2025 (shares fell 4% over the following quarter), a 94% trim in Q4 2025 (shares fell 18% over the following quarter), a 1562% increase in Q1 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 207.35K $14.46M New
Q4 2024 207.35K $13.70M Hold
Q1 2025 212.35K $16.15M Add
Q2 2025 377.35K $28.62M Add
Q3 2025 377.35K $27.55M Hold
Q4 2025 22.70K $1.93M Reduce
Q1 2026 377.35K $24.64M Add
Q2 2026 377.35K $29.11M Hold
Q3 2026 198.71K $17.52M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOLV and 13F data

SOLV (SOLVENTUM CORP) is a Health Care company. 41 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOLV

All SOLV fund holders →

FAQ

How long has GENERAL AMERICAN INVESTORS CO INC held SOLV?

GENERAL AMERICAN INVESTORS CO INC has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is GENERAL AMERICAN INVESTORS CO INC's current position in SOLV?

As of Q3 2026, GENERAL AMERICAN INVESTORS CO INC holds 198.71K shares of SOLV (SOLVENTUM CORP), valued at $17.52M, representing 1.11% of its reported portfolio and ranking #32.

Has GENERAL AMERICAN INVESTORS CO INC been buying or selling SOLV?

In the latest 13F filing (Q3 2026), GENERAL AMERICAN INVESTORS CO INC reduced its position in SOLV. The position peaked in Q2 2026 at 377.35K shares.

Which other funds hold SOLV?

Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.